Rationale: Health outcomes of people with coronavirus disease (COVID-19) range from no
symptoms to severe illness and death. Asthma, a common chronic lung disease, has been …

Objective As COVID-19 spreads across the world, there are concerns that people with
asthma are at a higher risk of acquiring the disease, or of poorer outcomes. This systematic …

Background Individual case series and cohort studies have reported conflicting results in
people with asthma on the vulnerability to and risk of mortality from coronavirus disease …

Background The Centers for Disease Control and Prevention advises that patients with
moderate to severe asthma belong to a high-risk group that is susceptible to severe …

Background The impact of asthma on coronavirus disease 2019 (COVID-19) remains largely
unknown. Objective To investigate the asthma prevalence among patients with COVID-19 …

The severity of the coronavirus disease (COVID-19) is associated with various comorbidities.
However, no studies have yet demonstrated the potential risk of respiratory failure and …

Background Several underlying conditions have been associated with severe acute
respiratory syndrome coronavirus 2 illness, but it remains unclear whether underlying …

Background Severe coronavirus disease-19 (COVID-19) presents with progressive
dyspnea, which results from acute lung inflammatory edema leading to hypoxia. As with …

Methods Anonymous data from the MSHS COVID-19 registry were downloaded, and ED
and inpatient encounters were selected. This dataset contained patient demographics …

The newly described severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
responsible for a pandemic (coronavirus disease 2019 [COVID-19]). It is now well …